Seeyond’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$809K Buy
17,493
+3,502
+25% +$152K 0.08% 339
2022
Q3
$541K Sell
13,991
-757
-5% -$30.4K 0.07% 404
2022
Q2
$549K Sell
14,748
-296
-2% -$12K 0.06% 436
2022
Q1
$666K Sell
15,044
-449
-3% -$19.5K 0.07% 425
2021
Q4
$658K Hold
15,493
0.06% 430
2021
Q3
$672K Sell
15,493
-13,010
-46% -$576K 0.06% 424
2021
Q2
$1.22M Sell
28,503
-633
-2% -$26.6K 0.11% 276
2021
Q1
$1.13M Buy
29,136
+427
+1% +$16.2K 0.11% 285
2020
Q4
$1.03M Sell
28,709
-1,947
-6% -$70.2K 0.11% 310
2020
Q3
$1.17M Buy
30,656
+339
+1% +$13.1K 0.13% 243
2020
Q2
$1.06M Buy
30,317
+7,568
+33% +$273K 0.12% 243
2020
Q1
$2.63M Sell
22,749
-8,321
-27% -$325K 0.36% 52
2019
Q4
$1.41M Sell
31,070
-8,739
-22% -$366K 0.15% 243
2019
Q3
$1.62M Buy
39,809
+27,266
+217% +$1.16M 0.17% 203
2019
Q2
$539K Sell
12,543
-16,970
-58% -$653K 0.06% 448
2019
Q1
$1.13M Buy
29,513
+6,881
+30% +$263K 0.11% 295
2018
Q4
$800K Buy
+22,632
New +$821K 0.11% 281

Other funds holding BSX

Seeyond's BSX Position: Q4 2022 in Review

Seeyond increased its Boston Scientific (BSX) stake by 25% in Q4 2022, buying an estimated $152K and bringing the position to 17,493 shares worth $809K. The position accounts for 0.08% of the portfolio, ranked #339.

Seeyond first reported a position in BSX in Q4 2018 and has held it in 17 quarters since. The position peaked at $2.63M in Q1 2020. 928 funds tracked by Wall St. Rank hold BSX as of Q4 2022.

  • Seeyond held 17,493 shares of Boston Scientific worth $809K as of Q4 2022.
  • Seeyond bought 3,502 Boston Scientific shares in Q4 2022, an estimated $152K.
  • Boston Scientific made up 0.08% of Seeyond's portfolio in Q4 2022, its #339 holding.
  • Seeyond first reported a position in Boston Scientific in Q4 2018 and has held it in 17 quarters since.
  • Seeyond's Boston Scientific position peaked at $2.63M in Q1 2020.
  • 928 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2022.

Based on Seeyond's 13F filing for Q4 2022, filed 13 Feb 2023.